rcca-header
Clinical Trials

A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Patients With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation

Type of Cancer
Multiple Myeloma
Phase
Division (Location)
East Brunswick, NJ, Freehold, NJ, Howell, NJ, Little Silver, NJ, Marmora, NJ, Mount Holly, NJ
Study ID
NCT#
Brief Description
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Patients With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.